top of page

Vendor Fair ~ Quality Improvement Series

Sat, Oct 26

|

The Inn At Longwood Medical

Event is open to RSVP! Check out Agenda for recent updates. Now offering 5.0 CEUs!!

Registration is Closed
See other events
Vendor Fair ~ Quality Improvement Series
Vendor Fair ~ Quality Improvement Series

Time & Location

Oct 26, 2019, 7:00 AM – 2:20 PM

The Inn At Longwood Medical, 342 Longwood Ave, Boston, MA 02115, USA

Guests

About The Event

Please register via the new link if you have not already: https://www.medlearninggroup.com/cme-programming/onq-ma-registration/

*AGENDA UPDATES* See below

Event has been increased to 5.0 CEUs! We look forward to seeing you there!

7:00 am – 7:55 am ~ Breakfast/Registration 

7:55 am – 8:00 am ~ Welcome/Announcements 

Session 1 8:00 am – 9:00 am *NSCLC* 

From the Nurses’ Perspective: Immuno-Oncology Treatment Options and Shared Decision-Making in Advanced NSCLC 

David S. Ettinger, MD, FACP, FCCP 

Alex Grass Professor of Oncology The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, MD 

Session 2 9:00 am – 10:00 am *Head and Neck Cancer*

The Oncology Nurses’ Role in the Management of Immunotherapy for Head and Neck Cancer 

Tanguy Y. Seiwert, MD 

Director, Head and Neck Oncology Disease Group Johns Hopkins Medicine Baltimore, MD 

10:00 am – 10:15 am ~ Break 

Session 3 10:15 am – 11:15 am *Acute Myeloid Leukemia*

Considerations for Oncology Nurses-Individualizing the Management of Acute Myeloid Leukemia: Genomics, Targeted Therapeutic Options, and Treatment Sequence

Michael R. Grunwald, MD 

Chief, Leukemia Division Department of Hematologic Oncology and Blood Disorders Levine Cancer Institute Charlotte, NC  

Lunch 11:15 am – 12:15 pm *Vendor Fair*

Session 4 12:15 pm – 1:15 pm *Melanoma*

The Importance of the Nurse-Patient Interaction in Optimizing Treatment of Advanced Melanoma 

Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN 

NYU Melanoma Program Clinical Cancer Center New York, NY 

Session 5 1:15 pm – 2:15 pm *HER2-Positive Beast Cancer*

The Use and Implementation of Targeted Therapy for Early HER2- Positive Breast Cancer: An Expanding Role of Nurse 

Andrea Fehl, CRNP, AOCNP 

Women’s Cancer Center Magee-Women’s Hospital University of Pittsburgh Medical Center Pittsburgh, Pennsylvania 

 

Share This Event

bottom of page